Dr. Guido A. Davidzon is a physician-scientist board certified in Nuclear Medicine. He graduated with honors from medical school in Argentina and completed an internship at Yale University New-Haven Hospital in Connecticut. He did his residency and was chief resident at Stanford Health Care. He completed a research fellowship in mitochondrial diseases at Columbia University in New York and, a U.S. National Library of Medicine Award supported, Biomedical Informatics fellowship at Massachusetts General Hospital in conjunction with a Science Masters at MIT.
Dr. Davidzon is Clinical Assistant Professor in the Department of Radiology at Stanford University and Boston University School of Medicine. His clinical specialties include early diagnostic imaging of cancer, coronary artery disease, and dementias using molecular probes as well as the treatment of cancer for which he employs targeted radiopharmaceutical therapy.
Dr. Davidzon investigates the use of machine learning in medical imaging to improve clinical outcomes, he is involved in the professional Society of Nuclear Medicine and Molecular Imaging. He serves as a peer reviewer for multiple medical journals. Dr. Davidzon is a native of Buenos Aires, Argentina and has lived in the U.S. for over a decade. He travels to Argentina frequently, with his wife and three sons.
Kaiser Permanente Santa Clara Medical Center
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 51 results.
Fite BZ, Hinostroza V, States L, Hicks-Nelson A, Baratto L, Kallianos K, Codari M, Yu B, Jha P, Shams M, Stoyanova T, Chapelin FF, Liu A, Rashidi A, Soto F, Quintana Y, Davidzon GA, Marycz K, Gibbs IC, Chonde DB, Patel CB, Daldrup-Link HE. Increasing Diversity in Radiology and Molecular Imaging: Current Challenges. Mol Imaging Biol. 2021 Apr 26. PMID: 33903986; PMCID: PMC8074707; DOI: 10.1007/s11307-021-01610-3;
Eyuboglu S, Angus G, Patel BN, Pareek A, Davidzon G, Long J, Dunnmon J, Lungren MP. Multi-task weak supervision enables anatomically-resolved abnormality detection in whole-body FDG-PET/CT. Nat Commun. 2021 03 25; 12(1):1880. PMID: 33767174; PMCID: PMC7994797; DOI: 10.1038/s41467-021-22018-1;
Baratto L, Song H, Duan H, Hatami N, Bagshaw H, Buyyounouski M, Hancock S, Shah SA, Srinivas S, Swift P, Moradi F, Davidzon GA, Iagaru A. PSMA- and GRPR-targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer. J Nucl Med. 2021 Mar 05. PMID: 33674398; DOI: 10.2967/jnumed.120.259630;
Nakamoto R, Zaba LC, Liang T, Reddy SA, Davidzon G, Aparici CM, Nguyen J, Moradi F, Iagaru A, Franc BL. Prognostic value of bone marrow metabolism on pretreatment 18F-FDG PET/CT in patients with metastatic melanoma treated with anti-PD-1 therapy. J Nucl Med. 2021 Feb 05. PMID: 33547210; DOI: 10.2967/jnumed.120.254482;
Nakamoto R, Harrison C, Song H, Guja KE, Hatami N, Nguyen J, Moradi F, Franc BL, Aparici CM, Davidzon G, Iagaru A. The Clinical Utility of 18F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval. Mol Imaging Biol. 2021 Jan 19. PMID: 33469884; DOI: 10.1007/s11307-021-01583-3;
Chen KT, Toueg TN, Koran MEI, Davidzon G, Zeineh M, Holley D, Gandhi H, Halbert K, Boumis A, Kennedy G, Mormino E, Khalighi M, Zaharchuk G. True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretation. Eur J Nucl Med Mol Imaging. 2021 Jan 08. PMID: 33416955; DOI: 10.1007/s00259-020-05151-9;
Trelle AN, Carr VA, Wilson EN, Swarovski MS, Hunt MP, Toueg TN, Tran TT, Channappa D, Corso NK, Thieu MK, Jayakumar M, Nadiadwala A, Guo W, Tanner NJ, Bernstein JD, Litovsky CP, Guerin SA, Khazenzon AM, Harrison MB, Rutt BK, Deutsch GK, Chin FT, Davidzon GA, Hall JN, Sha SJ, Fredericks CA, Andreasson KI, Kerchner GA, Wagner AD, Mormino EC. Association of CSF Biomarkers With Hippocampal-Dependent Memory in Preclinical Alzheimer Disease. Neurology. 2021 03 09; 96(10):e1470-e1481. PMID: 33408146; PMCID: PMC8055319; DOI: 10.1212/WNL.0000000000011477;
Zaharchuk G, Davidzon G. Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images. Semin Nucl Med. 2021 Mar; 51(2):134-142. PMID: 33509370; DOI: 10.1053/j.semnuclmed.2020.10.001;
Davidzon G, Franc B, Mari Aparici C, Moradi F, Nguyen J, Iagaru A. Obituary for Sanjiv Sam Gambhir, MD, PhD. Clin Nucl Med. 2020 11; 45(11):933. PMID: 32956118; DOI: 10.1097/RLU.0000000000003284;
Guja KE, Brown R, Girod B, Song H, Harrison C, Franc BL, Moradi F, Davidzon G, Iagaru A, Aparici CM. An unusual presentation of recurrent T cell lymphoma: angiocentric pattern of cutaneous uptake on [18F]FDG PET/CT. Eur J Nucl Med Mol Imaging. 2021 04; 48(4):1256-1257. PMID: 32918110; DOI: 10.1007/s00259-020-05026-z;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.